Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments
A novel multicellular model composed of epithelial ovarian cancer and fibroblast cells was developed as an in vitro platform to evaluate nanovector delivery and ultimately aid the development of targeted therapies. We hypothesized that the inclusion of peptide-based scaffold (PuraMatrix) in the sphe...
Guardado en:
Autores principales: | Stephen J. Winter, Hunter A. Miller, Jill M. Steinbach-Rankins |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aea05537f23f4bd7bb6de5e15a3ccf0d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
por: Benas Balandis, et al.
Publicado: (2021) -
miRNA Delivery by Nanosystems: State of the Art and Perspectives
por: Fernanda C. Moraes, et al.
Publicado: (2021) -
Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
por: Yi Ding, et al.
Publicado: (2021) -
Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide
por: Marco Cavaco, et al.
Publicado: (2021) -
Nanotechnology-Based Delivery Systems for Antimicrobial Peptides
por: Adewale Oluwaseun Fadaka, et al.
Publicado: (2021)